Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome
Authors:
Open Access
- 19 February 2020
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 25 (1) , 1-14
Abstract
Background: Viral myocarditis (VMC) is a type of cardiac inflammation that is generally caused by coxsackievirus B3 (CVB3) infection. Several MicroRNAs (miRNAs) are known to play crucial roles in VMC pathogenesis. MiR-15 is reportedly associated with myocardial injury, inflammatory responses and viral infection. Whether miR-15 affects the occurrence and development of VMC remains largely unknown. The roles of miR-15 and their underlying mechanisms in CVB3-stimulated H9c2 cells were assessed in this study.Methods: We infected H9c2 cells with CVB3 to establish a VMC cellular model. We then determined the effects of miR-15 inhibition on three cardiomyocyte injury markers: lactate dehydrogenase (LDH), creatine kinase-MB (CK-MB) and cardiac troponin-I (cTn-I). The impact on CVB3-induced cell apoptosis and pro-inflammatory cytokines was also investigated. The effects of miR-15 inhibition on NLRP3 inflammasome activation were also assessed. The target relationship between miR-15 and NOD-like receptor X1 (NLRX1) was determined using a luciferase reporter assay.Results: MiR-15 expression was significantly upregulated in H9c2 cells after CVB3 infection. Inhibition of miR-15 significantly decreased the CVB3-induced levels of LDH, CK-MB and cTn-I. It also elevated cell viability, reduced CVB3-induced cell apoptosis and decreased the generation of the interleukins IL-1β, IL-6 and IL-18. Furthermore, we determined that miR-15 inhibition suppressed NLRP3 inflammasome activation by downregulating NLRP3 and caspase-1 p20 expression. We found a direct target relationship between miR-15 and NLRX1. Additionally, inhibition of NLRX1 reversed the protective effects of miR-15 inhibition against CVB3-induced myocardial cell injury by regulating the NLRP3 inflammasome.Conclusion: Our results indicate that miR-15 inhibition alleviates CVB3-induced myocardial inflammation and cell injury. This may be partially due to NLRX1-mediated NLRP3 inflammasome inactivation.Keywords
This publication has 57 references indexed in Scilit:
- The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and HumansJournal of Crohn's and Colitis, 2016
- NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-λB signalingOncotarget, 2016
- MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiationArchives of Virology, 2013
- MicroRNA- 1 represses Cx43 expression in viral myocarditisMolecular and Cellular Biochemistry, 2011
- Viral Myocarditis: Potential Defense Mechanisms Within The Cardiomyocyte Against Virus InfectionFuture Microbiology, 2011
- Pattern Recognition Receptors and InflammationCell, 2010
- Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditisEuropean Heart Journal, 2009
- Pathogen Recognition and Innate ImmunityCell, 2006
- Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditisCardiovascular Pathology, 2003
- The InflammasomeMolecular Cell, 2002